—
C+
C+ The full Closelooknet — membership. Open the C+ overview

ConvaTec Group PLC (CTEC.L) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for CTEC.L, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
Who it is priced against Medical Instruments & Supplies · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against CTEC.L on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — ConvaTec Group PLC

CTEC.L in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
ConvaTec makes medical products for managing long-term health conditions, sold across Europe, North America and other regions. It offers advanced wound-care items for wounds linked to diabetes, injury and burns, ostomy devices for people living with a stoma after cancer or bowel disease, continence products for urinary issues tied to spinal or neurological conditions, and infusion sets used with insulin pumps and other continuous treatments. It sells through hospitals, pharmacies, distributors and wholesalers, reaching both healthcare providers and patients directly. The group is headquartered in London.
Where it sits in the stack
ConvaTec carries no seat in our index and sits outside the layers we map for the AI build-out. It belongs to our Healthcare sleeve, within the medical instruments and supplies part of our wider universe.
Who it is priced against
No peer group is set for ConvaTec in our data. The name the market most often compares it with is Smith & Nephew, another UK-listed maker of wound-care and medical devices.
Why Closelooknet tracks it
ConvaTec holds no index seat and no score in our system, and it has not yet drawn a quote in the diary's editions, so its coverage here stays limited to chart tracking rather than qualitative read.
What the diary watches
The diary watches whether ConvaTec's wound-care and ostomy volumes hold steady as healthcare providers adjust budgets, and whether it earns a fuller place in our coverage as medical device names draw more attention.

ConvaTec Group PLC (CTEC.L) trades on the LSE exchange in UK.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 2.54%, semi-annual · last 1.57 GBP on 2026-08-20

Dividends and capital return

What CTEC.L pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 5.55 GBP per share · a 2.54% yield on the 2026-10-06 close 2 distributions, paid twice a year 2026-10-06
  • Change on the year +10.1% against the prior twelve months prior twelve months 5.04 GBP per share
  • Last distribution 1.57 GBP per share as the price series records it, within days of the ex-date 2026-08-20
  • By calendar year 2025: 5.04 GBP (partial) · 2026: 5.55 GBP to date first distribution recorded in the three-year window: 2025-04-17

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-07

Quick answers

What is ConvaTec Group PLC (CTEC.L)?

ConvaTec Group PLC trades as CTEC.L on the LSE exchange (UK) in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is CTEC.L in a Closelooknet index?

Not currently — ConvaTec Group PLC is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

Where does CTEC.L trade against its moving averages?

Mixed moving-average stack: Trades -2.2% vs the 50-day and -1% vs the 200-day average, 14% below the 52-week high and +13.9% off the 52-week low; a golden cross printed 24 sessions ago. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does ConvaTec Group PLC compare with its peers?

Against its peer group (Medical Instruments & Supplies), ConvaTec Group PLC (CTEC.L) sits 14.0% below its 52-week high, 2.2% below its 50-day average; Ansell Ltd (ANN.AU) is 0.9% below, Fisher & Paykel Healthcare Corporation Ltd (FPH.AU) is 1.2% below, Intuitive Surgical Inc (ISRG) is 32.7% below. Put any of them next to CTEC.L in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

What does ConvaTec Group PLC do?

ConvaTec makes medical products for managing long-term health conditions, sold across Europe, North America and other regions. It offers advanced wound-care items for wounds linked to diabetes, injury and burns, ostomy devices for people living with a stoma after cancer or bowel disease, continence products for urinary issues tied to spinal or neurological conditions, and infusion sets used with insulin pumps and other continuous treatments. It sells through hospitals, pharmacies, distributors and wholesalers, reaching both healthcare providers and patients directly. No peer group is set for ConvaTec in our data. The name the market most often compares it with is Smith & Nephew, another UK-listed maker of wound-care and medical devices.

Where does ConvaTec Group PLC sit in the AI build-out?

ConvaTec carries no seat in our index and sits outside the layers we map for the AI build-out. It belongs to our Healthcare sleeve, within the medical instruments and supplies part of our wider universe. ConvaTec holds no index seat and no score in our system, and it has not yet drawn a quote in the diary's editions, so its coverage here stays limited to chart tracking rather than qualitative read.

Does ConvaTec Group PLC pay a dividend?

ConvaTec Group PLC has paid 5.55 GBP per share over the last twelve months, paid twice a year, a trailing yield of 2.54% on the 2026-10-06 close; the last distribution recorded in the price series was 1.57 GBP on 2026-08-20. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for CTEC.L, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.